Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect

Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect

Due to the theragnostic potential of mesoporous silica nanoparticles (MSNs), these were extensively investigated as a novel approach to improve clinical outcomes. Boasting an impressive array of formulations and modifications, MSNs demonstrate significant in vivo efficacy when used to identify or tr...

Full description

Bibliographic Details
Main Authors:	Alex N. Frickenstein, Jordan M. Hagood, Collin N. Britten, Brandon S. Abbott, Molly W. McNally, Catherine A. Vopat, Eian G. Patterson, William M. MacCuaig, Ajay Jain, Keisha B. Walters, Lacey R. McNally
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Pharmaceutics
Subjects:	mesoporous silica theranostics theragnostics nanomedicine cancer active targeting
Online Access:	https://www.mdpi.com/1999-4923/13/4/570

Similar Items

Mesoporous Silica Nanoparticles as Theranostic Antitumoral Nanomedicines
by: Alejandro Baeza, et al.
Published: (2020-10-01)

Radiation Dosimetry of Theragnostic Pairs for Isotopes of Iodine in IAZA
by: Hans-S. Jans, et al.
Published: (2022-08-01)

Toxicity Assessment of Mesoporous Silica Nanoparticles upon Intravenous Injection in Mice: Implications for Drug Delivery
by: William M. MacCuaig, et al.
Published: (2022-04-01)

Inhibitory effect of doxorubicin-loaded mesoporous silica nanoparticles on bladder cancer cells
by: SU Qiaoling, et al.
Published: (2021-12-01)

Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics
by: Yashaswi Dutta Gupta, et al.
Published: (2024-01-01)

Editorial: Molecular imaging for tracking drug delivery
by: Zheng Han, et al.
Published: (2023-05-01)

Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma
by: Zheng W, et al.
Published: (2022-07-01)

Theranostic Mesoporous Silica Nanoparticles Loaded With a Curcumin-Naphthoquinone Conjugate for Potential Cancer Intervention
by: Lara G. Freidus, et al.
Published: (2021-05-01)

In vitro Antitumor Properties of Fucoidan-Coated, Doxorubicin-Loaded, Mesoporous Polydopamine Nanoparticles
by: Hongping Xu, et al.
Published: (2022-12-01)

Encapsulation of Anti-Tuberculosis Drugs within Mesoporous Silica and Intracellular Antibacterial Activities
by: Xin Xia, et al.
Published: (2014-09-01)

Prioritising breast cancer theranostics: A current medical longing in oncology
by: Prem N. Pandey, et al.
Published: (2021-01-01)

Characterization of a Mesoporous Silica Nanoparticle Formulation Loaded with Mitomycin C Lipidic Prodrug (MLP) and In Vitro Comparison with a Clinical-Stage Liposomal Formulation of MLP
by: Miguel Manzano, et al.
Published: (2022-07-01)

Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A “Raisin-Cake”-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery
by: Fatemeh Farjadian, et al.
Published: (2023-10-01)

PSMA theragnostics for metastatic castration resistant prostate cancer
by: Hong Song, et al.
Published: (2022-08-01)

Role of mesoporous silica nanoparticles for the drug delivery applications
by: Baranya Murugan, et al.
Published: (2020-01-01)

Theranostic mesoporous platinum nanoplatform delivers halofuginone to remodel extracellular matrix of breast cancer without systematic toxicity
by: Jie Zhang, et al.
Published: (2023-07-01)

Theranostics for Triple-Negative Breast Cancer
by: Hyeryeon Choi, et al.
Published: (2023-01-01)

Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
by: Suphalak Khamruang Marshall, et al.
Published: (2022-10-01)

Advances in the Field of Micro- and Nanotechnologies Applied to Extracellular Vesicle Research: Take-Home Message from ISEV2021
by: Silvia Picciolini, et al.
Published: (2021-12-01)

Advances in nanoparticles-based approaches in cancer theranostics
by: Muhammad Akmal Raheem, et al.
Published: (2023-07-01)

Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics
by: Qian Wu, et al.
Published: (2023-01-01)

Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis
by: Kia P, et al.
Published: (2023-03-01)

Editorial: Functionalized Nanocarriers for Theranostics
by: Stefano Leporatti, et al.
Published: (2020-11-01)

Fluorescent quantum dots: An insight on synthesis and potential biological application as drug carrier in cancer
by: P. Tandale, et al.
Published: (2021-07-01)

Development of Multifunctional Biopolymeric Auto-Fluorescent Micro- and Nanogels as a Platform for Biomedical Applications
by: Arti Vashist, et al.
Published: (2020-04-01)

Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities
by: Panoraia I. Siafaka, et al.
Published: (2021-01-01)

Molecular Imaging of Inflammatory Disease
by: Meredith A. Jones, et al.
Published: (2021-02-01)

Frontiers in Preparations and Promising Applications of Mesoporous Polydopamine for Cancer Diagnosis and Treatment
by: Hualin Ma, et al.
Published: (2022-12-01)

Emerging and Innovative Theranostic Approaches for Mesoporous Silica Nanoparticles in Hepatocellular Carcinoma: Current Status and Advances
by: Yaoye Tao, et al.
Published: (2020-03-01)

Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs)
by: Lorena-Andreea Bocancia-Mateescu, et al.
Published: (2023-06-01)

Bacteriophages as Solid Tumor Theragnostic Agents
by: Srivani Veeranarayanan, et al.
Published: (2021-12-01)

PET Oncological Radiopharmaceuticals: Current Status and Perspectives
by: Mai Lin, et al.
Published: (2022-10-01)

Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders
by: Bhagavathi Sundaram Sivamaruthi, et al.
Published: (2023-01-01)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
by: Jingyun Cheng, et al.
Published: (2023-12-01)

From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma
by: Kamil J. Synoradzki, et al.
Published: (2024-02-01)

Recent Development of Supramolecular Cancer Theranostics Based on Cyclodextrins: A Review
by: Wenting Hu, et al.
Published: (2023-04-01)

Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
by: Yiming Xu, et al.
Published: (2023-07-01)

Theranostic nanoplatform to target macrophages enables the inhibition of atherosclerosis progression and fluorescence imaging of plaque in ApoE(−/−) mice
by: Qi Wang, et al.
Published: (2021-07-01)

Design of a novel theranostic nanomedicine: synthesis and physicochemical properties of a biocompatible polyphosphazene–platinum(II) conjugate
by: Avaji PG, et al.
Published: (2016-03-01)

Designing and Immunomodulating Multiresponsive Nanomaterial for Cancer Theranostics
by: Amreen Khan, et al.
Published: (2021-01-01)